呼吸器用吸入器の世界市場:産業分析・機会分析

◆英語タイトル:Respiratory Inhaler Devices Market: Global Industry Analysis and Opportunity Assessment, 2015 – 2025
◆商品コード:FMI609090
◆発行会社(調査会社):Future Market Insights
◆発行日:2015年10月27日
◆ページ数:267
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Individual (single user)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
EnterpriseUSD10,000 ⇒換算¥1,140,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。



※本調査レポートでは、呼吸器用吸入器の世界市場について調査・分析し、市場概観、呼吸器用吸入器の世界市場規模、市場規模予測、地域別分析(アメリカ、ヨーロッパ、アジア等)、セグメント別市場分析、競争状況、呼吸器用吸入器市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

Future Market Insights offers a 10-year forecast of the global respiratory inhaler devices market between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 4.3% during the projected period. This study demonstrates market dynamics and trends in all seven regions that influence the current environment and future status of the respiratory inhaler devices market over the forecast period.
Report Description

This Future Market Insights report examines the respiratory inhaler devices market for the period 2015–2025. The primary objective of the report is to offer insights into developments in the respiratory inhaler devices market that are significantly transforming global businesses and enterprises. Increasing prevalence of asthma, COPD and other respiratory diseases coupled with rising awareness is predicted to increase usages of respiratory inhaler devices worldwide. This is expected to bolster growth of the respiratory inhaler devices market over the next five to six years. Increasing demand for inhalation respiratory inhaler devices for controlling asthma and other respiratory disease, especially among children and elderly population, is expected to drive growth of respiratory inhaler devices market during the forecast period. Companies are focusing on regions and sections where prevalence of asthma, and chronic lung disease are increasing such as Asia Pacific and MEA.

The respiratory inhaler devices market report begins with an overview of the respiratory inhaler devices market in terms of value. This section includes FMI analysis of key trends, drivers and restraints and opportunity, which are factors influencing growth of the respiratory inhaler devices market. Impact analysis of key growth drivers and restraints based on the weighted average model is included in the respiratory inhaler devices market report to better equip clients with crystal clear decision-making insights.

The global respiratory inhaler devices market is segmented on the basis of products type into dry powder inhaler (DPI), metered dose inhaler (MDI) and nebuliser. Nebuliser is further sub-segmented into compressed air nebuliser, ultrasonic nebuliser and mesh nebuliser. A detailed analysis has been provided for every segment and sub-segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.

The next section of the report highlights respiratory inhaler devices adoption by region. It provides a market outlook for 2015–2025 and sets the forecast within the context of the respiratory inhaler devices market. The study discusses key regional trends contributing to growth of the respiratory inhaler devices market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East & Africa.

The above sections – by product type and region – evaluate the present scenario and growth prospects of the respiratory inhaler devices market for the period 2015 –2025. We have considered 2014 as the base year and provide data for the forecast period.

To ascertain respiratory inhaler devices market size, we have also considered revenue generated by manufacturers. The forecast presented here assesses the total revenue by value across the respiratory inhaler devices market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the respiratory inhaler devices market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis, based on supply side, downstream industry demand and the economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse on the basis of key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the respiratory inhaler devices market.

The respiratory inhaler devices segments in terms of product and regions are analysed in terms of Basis Point Share (BPS) to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identification of various key trends in the respiratory inhaler devices market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the respiratory inhaler devices market.

To understand key growth segments in terms of growth and adoption for dry powder inhaler, metered dose inhaler and nebuliser across the globe in the near future, Future Market Insights developed the respiratory inhaler devices market ‘Attractiveness Index’. The resulting index should help providers identify real market opportunities.

In the final section of the report, respiratory inhaler devices ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, based on categories of providers in the value chain of the respiratory inhaler devices product portfolio and key differentiators. Key categories of providers covered in the report are respiratory inhaler devices manufacturers. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the respiratory inhaler devices value chain and the potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in respiratory inhaler devices marketplace.

Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings and recent developments in the respiratory inhaler devices market. Key competitors covered in terms of manufacturers include AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare Europe B.V., PARI Medical Holding and Teva Pharmaceutical Industries Ltd.

Key Segments Covered

Product Type
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Ultrasonic Nebulizer
Compressed Air Nebulizer
Mesh Nebulizer
By Disease Indication
Asthma
COPD
Pulmonary Arterial Hypertension
Others Respiratory Disease
By Technology
Manually Operated Inhaler Devices
Digitally Operated Inhaler Devices

Key Regions/Countries Covered

North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Western Europe
EU5
Nordics
BENELUX
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific Excluding Japan (APEJ)
Greater China
India
ASEAN
Australia and New Zealand
Rest of APEJ
Japan
Middle East & Africa
GCC
South Africa
Israel
Turkey
Rest of MEA

Key Companies

AstraZeneca
Beximco Pharmaceuticals Ltd.
Boehringer Ingelheim GmbH
Cipla Ltd.
GlaxoSmithKline plc
Koninklijke Philips N.V.
Merck & Co., Inc.
OMRON Healthcare Europe B.V.
PARI Medical Holding
Teva Pharmaceutical Industries Ltd.

【レポートの目次】

able Of Content
1. Assumptions and Acronyms Used
2. Research Methodology
3. Executive Summary
4. Respiratory Inhaler Devices Market Overview
4.1. Introduction
4.2. Respiratory Inhaler Devices Market Definition
4.3. Parent Market Overview
4.4. Respiratory Inhaler Devices Market Product Overview
4.5. Respiratory Inhaler Devices Market Dynamics
4.5.1. Drivers
4.5.2. Restraints
4.5.3. Trends
5. Global Respiratory Inhaler Devices Market Analysis, By Product
5.1. Introduction
5.1.1. Y-o-Y Growth Comparison, By Product
5.1.2. Market Share & Basis Point (BPS) Analysis, By Product
5.2. Market Forecast, By Product
5.2.1. Dry Powder Inhaler
5.2.1.1. Absolute $ Opportunity
5.2.1.2. Market Value and Volume Forecast, By Region
5.2.2. Metered Dose Inhaler
5.2.2.1. Absolute $ Opportunity
5.2.2.2. Market Value and Volume Forecast, By Region
5.2.3. Nebulizers
5.2.3.1. Absolute $ Opportunity
5.2.3.2. Market Value and Volume Forecast, By Region
5.2.3.3. Compressed Air Nebulizers
5.2.3.3.1. Absolute $ Opportunity
5.2.3.3.2. Market Value and Volume Forecast, By Region
5.2.3.4. Ultrasonic Nebulizers
5.2.3.4.1. Absolute $ Opportunity
5.2.3.4.2. Market Value and Volume Forecast, By Region
5.2.3.5. Mesh Nebulizers
5.2.3.5.1. Absolute $ Opportunity
5.2.3.5.2. Market Value and Volume Forecast, By Region
5.3. Market Attractiveness Analysis, By Product
6. Global Market Analysis, By Technology
6.1. Introduction
6.1.1. Y-o-Y Growth Comparison, By Technology
6.1.2. Market Share & Basis Point (BPS) Analysis, By Technology
6.2. Market Forecast, By Technology
6.2.1. Manually Operated Inhaler Devices
6.2.1.1. Absolute $ Opportunity
6.2.1.2. Market Value and Volume Forecast, By Region
6.2.2. Digitally Operated Inhaler Devices
6.2.2.1. Absolute $ Opportunity
6.2.2.2. Market Value and Volume Forecast, By Region
6.3. Market Attractiveness Analysis, By Technology
7. Global Market Analysis, By Disease Indication
7.1. Introduction
7.1.1. Y-o-Y Growth Comparison, By Disease Indication
7.1.2. Market Share & Basis Point (BPS) Analysis, By Disease Indication
7.2. Market Forecast, By Disease Indication
7.2.1. Asthma
7.2.1.1. Absolute $ Opportunity
7.2.1.2. Market Value and Volume Forecast, By Region
7.2.2. Chronic Obstructive Pulmonary Disease (COPD)
7.2.2.1. Absolute $ Opportunity
7.2.2.2. Market Value and Volume Forecast, By Region
7.2.3. Pulmonary Arterial Hypertension
7.2.3.1. Absolute $ Opportunity
7.2.3.2. Market Value and Volume Forecast, By Region
7.2.4. Others
7.2.4.1. Absolute $ Opportunity
7.2.4.2. Market Value and Volume Forecast, By Region
7.3. Market Attractiveness Analysis, By Disease Indication
8. Global Respiratory Inhaler Devices Market Analysis, By Region
8.1. Introduction
8.1.1. Y-o-Y Growth Projections, By Region
8.1.2. Market Share & Basis Point (BPS) Analysis, By Region
8.2. Market Forecast, By Region
8.2.1. North America Market Value and Volume Forecast
8.2.2. Latin America Market Value and Volume Forecast
8.2.3. Western Europe Market Value and Volume Forecast
8.2.4. Eastern Europe Market Value and Volume Forecast
8.2.5. Asia Pacific Excluding Japan Market Value and Volume Forecast
8.2.6. Japan Market Value and Volume Forecast
8.2.7. MEA Market Value and Volume Forecast
8.3. Regional Attractiveness Analysis
9. North America Respiratory Inhaler Devices Market Analysis
9.1. Introduction
9.2. Y-o-Y Growth Projections, By Country
9.3. Market Share & Basis Point (BPS) Analysis, By Country
9.4. North America Market Forecast
9.5. Market Value and Volume Forecast, By Country
9.5.1. US Value and Volume Forecast
9.5.2. Canada Value and Volume Forecast
9.6. Market Value and Volume Forecast, By Product
9.6.1. Dry Powder Inhaler
9.6.2. Metered Dose Inhaler
9.6.3. Nebulizers
9.6.3.1. Compressed Air Nebulizers
9.6.3.2. Ultrasonic Nebulizers
9.6.3.3. Mesh Nebulizers
9.7. Market Value and Volume Forecast, By Technology
9.7.1. Manually Operated Inhaler Devices
9.7.2. Digitally Operated Inhaler Devices
9.8. Market Value and Volume Forecast, By Disease Indication
9.8.1. Asthma
9.8.2. Chronic Obstructive Pulmonary Disease (COPD)
9.8.3. Pulmonary Arterial Hypertension
9.8.4. Others
9.9. Market Attractiveness Analysis
9.9.1. By Country
9.9.2. By Product
9.9.3. By Technology
9.9.4. By Disease Indication
10. Latin America Respiratory Inhaler Devices Market Analysis
10.1. Introduction
10.2. Y-o-Y Growth Projections, By Country
10.3. Market Share & Basis Point (BPS) Analysis, By Country
10.4. Latin America Market Forecast
10.5. Market Value and Volume Forecast, By Country
10.5.1. Argentina Value and Volume Forecast
10.5.2. Brazil Value and Volume Forecast
10.5.3. Mexico Value and Volume Forecast
10.5.4. Rest of Latin America Value and Volume Forecast
10.6. Market Value and Volume Forecast, By Product
10.6.1. Dry Powder Inhaler
10.6.2. Metered Dose Inhaler
10.6.3. Nebulizers
10.6.3.1. Compressed Air Nebulizers
10.6.3.2. Ultrasonic Nebulizers
10.6.3.3. Mesh Nebulizers
10.7. Market Value and Volume Forecast, By Technology
10.7.1. Manually Operated Inhaler Devices
10.7.2. Digitally Operated Inhaler Devices
10.8. Market Value and Volume Forecast, By Disease Indication
10.8.1. Asthma
10.8.2. Chronic Obstructive Pulmonary Disease (COPD)
10.8.3. Pulmonary Arterial Hypertension
10.8.4. Others
10.9. Market Attractiveness Analysis
10.9.1. By Country
10.9.2. By Product
10.9.3. By Technology
10.9.4. By Disease Indication
11. Western Europe Respiratory Inhaler Devices Market Analysis
11.1. Introduction
11.2. Y-o-Y Growth Projections, By Country / Region
11.3. Market Share & Basis Point (BPS) Analysis, By Country
11.4. Western Europe Market Forecast
11.5. Market Value and Volume Forecast, By Country/Region
11.5.1. Germany Value and Volume Forecast
11.5.2. United Kingdom Value and Volume Forecast
11.5.3. France Value and Volume Forecast
11.5.4. Italy Value and Volume Forecast
11.5.5. Spain Value and Volume Forecast
11.5.6. NORDIC Value and Volume Forecast
11.5.7. BENELUX Value and Volume Forecast
11.5.8. Rest of Western Europe Value and Volume Forecast
11.6. Market Value and Volume Forecast, By Product
11.6.1. Dry Powder Inhaler
11.6.2. Metered Dose Inhaler
11.6.3. Nebulizers
11.6.3.1. Compressed Air Nebulizers
11.6.3.2. Ultrasonic Nebulizers
11.6.3.3. Mesh Nebulizers
11.7. Market Value and Volume Forecast, By Technology
11.7.1. Manually Operated Inhaler Devices
11.7.2. Digitally Operated Inhaler Devices
11.8. Market Value and Volume Forecast, By Disease Indication
11.8.1. Asthma
11.8.2. Chronic Obstructive Pulmonary Disease (COPD)
11.8.3. Pulmonary Arterial Hypertension
11.8.4. Others
11.9. Market Attractiveness Analysis
11.9.1. By Country
11.9.2. By Product
11.9.3. By Technology
11.9.4. By Disease Indication
12. Eastern Europe Respiratory Inhaler Devices Market Analysis
12.1. Introduction
12.2. Y-o-Y Growth Projections, By Country / Region
12.3. Market Share & Basis Point (BPS) Analysis, By Country
12.4. Eastern Europe Market Forecast
12.5. Market Value and Volume Forecast, By Country/Region
12.5.1. Poland Value and Volume Forecast
12.5.2. Russia Value and Volume Forecast
12.5.3. Rest of Eastern Europe Value and Volume Forecast
12.6. Market Value and Volume Forecast, By Product
12.6.1. Dry Powder Inhaler
12.6.2. Metered Dose Inhaler
12.6.3. Nebulizers
12.6.3.1. Compressed Air Nebulizers
12.6.3.2. Ultrasonic Nebulizers
12.6.3.3. Mesh Nebulizers
12.7. Market Value and Volume Forecast, By Technology
12.7.1. Manually Operated Inhaler Devices
12.7.2. Digitally Operated Inhaler Devices
12.8. Market Value and Volume Forecast, By Disease Indication
12.8.1. Asthma
12.8.2. Chronic Obstructive Pulmonary Disease (COPD)
12.8.3. Pulmonary Arterial Hypertension
12.8.4. Others
12.9. Market Attractiveness Analysis
12.9.1. By Country
12.9.2. By Product
12.9.3. By Technology
12.9.4. By Disease Indication
13. Asia Pacific Excluding Japan Respiratory Inhaler Devices Market Analysis
13.1. Introduction
13.2. Y-o-Y Growth Projections, By Country
13.3. Market Share & Basis Point (BPS) Analysis, By Country
13.4. Asia Pacific Excluding Japan Market Forecast
13.5. Market Value and Volume Forecast, By Country/Region
13.5.1. Greater China Value and Volume Forecast
13.5.2. India Value and Volume Forecast
13.5.3. ASEAN Value and Volume Forecast
13.5.4. Australia and New Zealand Value and Volume Forecast
13.5.5. Rest of APAC Value and Volume Forecast
13.6. Market Value and Volume Forecast, By Product
13.6.1. Dry Powder Inhaler
13.6.2. Metered Dose Inhaler
13.6.3. Nebulizers
13.6.3.1. Compressed Air Nebulizers
13.6.3.2. Ultrasonic Nebulizers
13.6.3.3. Mesh Nebulizers
13.7. Market Value and Volume Forecast, By Technology
13.7.1. Manually Operated Inhaler Devices
13.7.2. Digitally Operated Inhaler Devices
13.8. Market Value and Volume Forecast, By Disease Indication
13.8.1. Asthma
13.8.2. Chronic Obstructive Pulmonary Disease (COPD)
13.8.3. Pulmonary Arterial Hypertension
13.8.4. Others
13.9. Market Attractiveness Analysis
13.9.1. By Country
13.9.2. By Product
13.9.3. By Technology
13.9.4. By Disease Indication
14. Japan Respiratory Inhaler Devices Market Analysis
14.1. Introduction
14.2. Y-o-Y Growth Projections, By Country
14.3. Market Share & Basis Point (BPS) Analysis, By Country
14.4. Japan Market Forecast
14.5. Market Value and Volume Forecast, By Product
14.5.1. Dry Powder Inhaler
14.5.2. Metered Dose Inhaler
14.5.3. Nebulizers
14.5.3.1. Compressed Air Nebulizers
14.5.3.2. Ultrasonic Nebulizers
14.5.3.3. Mesh Nebulizers
14.6. Market Value and Volume Forecast, By Technology
14.6.1. Manually Operated Inhaler Devices
14.6.2. Digitally Operated Inhaler Devices
14.7. Market Value and Volume Forecast, By Disease Indication
14.7.1. Asthma
14.7.2. Chronic Obstructive Pulmonary Disease (COPD)
14.7.3. Pulmonary Arterial Hypertension
14.7.4. Others
14.8. Market Attractiveness Analysis
14.8.1. By Country
14.8.2. By Product
14.8.3. By Technology
14.8.4. By Disease Indication
15. MEA Respiratory Inhaler Devices Market Analysis
15.1. Introduction
15.2. Y-o-Y Growth Projections, By Country / Region
15.3. Market Share & Basis Point (BPS) Analysis, By Country
15.4. MEA Market Forecast
15.5. Market Value and Volume Forecast, By Country/Region
15.5.1. GCC Value and Volume Forecast
15.5.2. North Africa Value and Volume Forecast
15.5.3. South Africa Value and Volume Forecast
15.5.4. Rest of MEA Value and Volume Forecast
15.6. Market Value and Volume Forecast, By Product
15.6.1. Dry Powder Inhaler
15.6.2. Metered Dose Inhaler
15.6.3. Nebulizers
15.6.3.1. Compressed Air Nebulizers
15.6.3.2. Ultrasonic Nebulizers
15.6.3.3. Mesh Nebulizers
15.7. Market Value and Volume Forecast, By Technology
15.7.1. Manually Operated Inhaler Devices
15.7.2. Digitally Operated Inhaler Devices
15.8. Market Value and Volume Forecast, By Disease Indication
15.8.1. Asthma
15.8.2. Chronic Obstructive Pulmonary Disease (COPD)
15.8.3. Pulmonary Arterial Hypertension
15.8.4. Others
15.9. Market Attractiveness Analysis
15.9.1. By Country
15.9.2. By Product
15.9.3. By Technology
15.9.4. By Disease Indication
15.10. Drivers & Restraints: Impact Analysis
16. Competition Landscape
16.1. Major Mergers and Acquisitions
16.2. Company Profiles
16.2.1. Revenue
16.2.2. Products/Brand Offerings
16.2.3. Company Highlights
16.2.4. Strategies
16.3. AstraZeneca plc
16.4. Beximco Pharmaceuticals Ltd
16.5. Boehringer Ingelheim GmbH
16.6. Cipla Ltd
16.7. GlaxoSmithKline plc
16.8. Koninklijke Philips N.V.
16.9. Merck & Co., Inc.
16.10. OMRON Healthcare Europe B.V.
16.11. PARI Medical Holding
16.12. Teva Pharmaceutical Industries Ltd



【レポートのキーワード】

呼吸器、吸入器

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[呼吸器用吸入器の世界市場:産業分析・機会分析]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月10日現在 219,328 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆